Literature DB >> 9069579

Selection of retrovirally transduced cells to enhance the efficiency of gene therapy.

J A Medin1, S Karlsson.   

Abstract

Retrovirally mediated gene transfer is the approach of choice for many laboratories interested in gene therapy. One problem, however, is that the efficiency of therapeutic gene transfer to some important target cells is low. A strategy employed by a number of investigators to overcome this shortcoming is to construct recombinant viruses that employ selection modalities. These strategies can be classified broadly into either metabolic or cell-surface selection strategies. This article examines each selection approach and notes their important strengths and weaknesses. Further, the various gene products used in each approach to effect sorting of transduced cells is detailed.

Mesh:

Substances:

Year:  1997        PMID: 9069579

Source DB:  PubMed          Journal:  Proc Assoc Am Physicians        ISSN: 1081-650X


  4 in total

Review 1.  Gene therapy for Fabry disease.

Authors:  C Siatskas; J A Medin
Journal:  J Inherit Metab Dis       Date:  2001       Impact factor: 4.982

2.  Preselective gene therapy for Fabry disease.

Authors:  G Qin; T Takenaka; K Telsch; L Kelley; T Howard; T Levade; R Deans; B H Howard; H L Malech; R O Brady; J A Medin
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-06       Impact factor: 11.205

Review 3.  Platelets as delivery systems for disease treatments.

Authors:  Qizhen Shi; Robert R Montgomery
Journal:  Adv Drug Deliv Rev       Date:  2010-07-07       Impact factor: 15.470

4.  Long-term enzyme correction and lipid reduction in multiple organs of primary and secondary transplanted Fabry mice receiving transduced bone marrow cells.

Authors:  T Takenaka; G J Murray; G Qin; J M Quirk; T Ohshima; P Qasba; K Clark; A B Kulkarni; R O Brady; J A Medin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.